| Term | Count | % | | DRUG INEFFECTIVE | 4022 | 9.21% |
| TREATMENT FAILURE | 3069 | 7.03% |
| OCULAR HYPERAEMIA | 2292 | 5.25% |
| EYE IRRITATION | 1785 | 4.09% |
| MADAROSIS | 1373 | 3.14% |
| EYE PRURITUS | 1306 | 2.99% |
| ERYTHEMA OF EYELID | 1006 | 2.30% |
| EYE PAIN | 878 | 2.01% |
| HYPERSENSITIVITY | 845 | 1.93% |
| VISION BLURRED | 810 | 1.85% |
| INTRAOCULAR PRESSURE INCREASED | 700 | 1.60% |
| FATIGUE | 667 | 1.53% |
| OFF LABEL USE | 665 | 1.52% |
| HEADACHE | 638 | 1.46% |
| EYE SWELLING | 634 | 1.45% |
| DRY EYE | 629 | 1.44% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 580 | 1.33% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.23% |
| EYELIDS PRURITUS | 528 | 1.21% |
| DYSPNOEA | 519 | 1.19% |
| ERYTHEMA | 504 | 1.15% |
| DIZZINESS | 500 | 1.14% |
| INCORRECT DOSE ADMINISTERED | 483 | 1.11% |
| SKIN HYPERPIGMENTATION | 480 | 1.10% |
| NAUSEA | 474 | 1.09% |
| DIARRHOEA | 467 | 1.07% |
| FALL | 440 | 1.01% |
| VISUAL IMPAIRMENT | 437 | 1.00% |
| ASTHENIA | 428 | 0.98% |
| EYELID OEDEMA | 419 | 0.96% |
| PRURITUS | 410 | 0.94% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.92% |
| PAIN | 380 | 0.87% |
| EYELID IRRITATION | 367 | 0.84% |
| LACRIMATION INCREASED | 367 | 0.84% |
| DEATH | 361 | 0.83% |
| RASH | 337 | 0.77% |
| PRODUCT DOSE OMISSION ISSUE | 336 | 0.77% |
| CATARACT | 327 | 0.75% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 314 | 0.72% |
| GLAUCOMA | 313 | 0.72% |
| EYE DISCHARGE | 301 | 0.69% |
| MALAISE | 301 | 0.69% |
| THERAPEUTIC RESPONSE DECREASED | 296 | 0.68% |
| GROWTH OF EYELASHES | 294 | 0.67% |
| SKIN DISCOLOURATION | 284 | 0.65% |
| VISUAL ACUITY REDUCED | 284 | 0.65% |
| TRICHORRHEXIS | 281 | 0.64% |
| BLEPHARAL PIGMENTATION | 278 | 0.64% |
| DRUG DOSE OMISSION | 272 | 0.62% |
| PNEUMONIA | 272 | 0.62% |
| VOMITING | 259 | 0.59% |
| ARTHRALGIA | 257 | 0.59% |
| PAIN IN EXTREMITY | 255 | 0.58% |
| DRUG HYPERSENSITIVITY | 249 | 0.57% |
| COUGH | 248 | 0.57% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 242 | 0.55% |
| WEIGHT DECREASED | 240 | 0.55% |
| PRODUCT QUALITY ISSUE | 234 | 0.54% |
| INSOMNIA | 231 | 0.53% |
| HYPERTENSION | 230 | 0.53% |
| EYE DISORDER | 215 | 0.49% |
| FOREIGN BODY SENSATION IN EYES | 207 | 0.47% |
| DECREASED APPETITE | 199 | 0.46% |
| BACK PAIN | 192 | 0.44% |
| BLOOD PRESSURE INCREASED | 190 | 0.44% |
| PRODUCT PACKAGING QUANTITY ISSUE | 188 | 0.43% |
| CONSTIPATION | 187 | 0.43% |
| HAIR GROWTH ABNORMAL | 187 | 0.43% |
| OCULAR DISCOMFORT | 187 | 0.43% |
| GAIT DISTURBANCE | 186 | 0.43% |
| ANAEMIA | 183 | 0.42% |
| ANXIETY | 178 | 0.41% |
| HYPOTENSION | 173 | 0.40% |
| CONDITION AGGRAVATED | 170 | 0.39% |
| PYREXIA | 170 | 0.39% |
| FEELING ABNORMAL | 164 | 0.38% |
| URINARY TRACT INFECTION | 163 | 0.37% |
| PHOTOPHOBIA | 162 | 0.37% |
| DEPRESSION | 154 | 0.35% |
| CONFUSIONAL STATE | 151 | 0.35% |
| EXPIRED PRODUCT ADMINISTERED | 151 | 0.35% |
| SOMNOLENCE | 149 | 0.34% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.34% |
| PERIPHERAL SWELLING | 147 | 0.34% |
| MYALGIA | 146 | 0.33% |
| OEDEMA PERIPHERAL | 146 | 0.33% |
| SWELLING OF EYELID | 146 | 0.33% |
| BLINDNESS | 145 | 0.33% |
| CHEST PAIN | 145 | 0.33% |
| ABDOMINAL DISCOMFORT | 144 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 144 | 0.33% |
| EYELID PAIN | 143 | 0.33% |
| NASOPHARYNGITIS | 141 | 0.32% |
| BLEPHARITIS | 140 | 0.32% |
| BLOOD GLUCOSE INCREASED | 140 | 0.32% |
| BURNING SENSATION | 140 | 0.32% |
| ALOPECIA | 139 | 0.32% |
| ATRIAL FIBRILLATION | 139 | 0.32% |
| WEIGHT INCREASED | 138 | 0.32% |
| Total | 43678 | |